Immunotech Biopharm Ltd (6978.HK)

HKD 2.47

(8.33%)

Total Assets Summary of Immunotech Biopharm Ltd

Immunotech Biopharm Ltd's latest annual total assets in 2023 was 846.28 Million CNY , down -3.77% from previous year.
Immunotech Biopharm Ltd's latest quarterly total assets in 2024 Q1 was 719.71 Million CNY , down -14.96% from previous quarter.
Immunotech Biopharm Ltd reported annual total assets of 879.43 Million CNY in 2022, down -19.88% from previous year.
Immunotech Biopharm Ltd reported annual total assets of 1.09 Billion CNY in 2021, down -9.3% from previous year.
Immunotech Biopharm Ltd reported quarterly total assets of 719.71 Million CNY for 2024 Q1, down -14.96% from previous quarter.
Immunotech Biopharm Ltd reported quarterly total assets of 1.03 Billion CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of Immunotech Biopharm Ltd (2023 - 2018)

Historical Annual Total Assets of Immunotech Biopharm Ltd (2023 - 2018)

Year	Total Assets	Total Assets Growth
2023	846.28 Million CNY	-3.77%
2022	879.43 Million CNY	-19.88%
2021	1.09 Billion CNY	-9.3%
2020	1.21 Billion CNY	190.24%
2019	416.97 Million CNY	49.34%
2018	279.21 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	719.71 Million CNY	0.0%
2024 Q1	719.71 Million CNY	-14.96%
2023 Q2	1.03 Billion CNY	0.0%
2023 FY	846.28 Million CNY	-3.77%
2023 Q1	1.03 Billion CNY	18.01%
2023 Q4	846.28 Million CNY	0.0%
2023 Q3	846.28 Million CNY	-18.45%
2022 Q4	879.43 Million CNY	0.0%
2022 Q3	879.43 Million CNY	-10.04%
2022 Q2	977.54 Million CNY	0.0%
2022 Q1	977.54 Million CNY	-10.94%
2022 FY	879.43 Million CNY	-19.88%
2021 Q1	1.09 Billion CNY	-9.33%
2021 Q2	1.09 Billion CNY	0.0%
2021 FY	1.09 Billion CNY	-9.3%
2021 Q4	1.09 Billion CNY	0.0%
2021 Q3	1.09 Billion CNY	0.04%
2020 Q4	1.21 Billion CNY	0.0%
2020 FY	1.21 Billion CNY	190.24%
2020 Q3	1.21 Billion CNY	232.05%
2020 Q2	364.47 Million CNY	0.0%
2020 Q1	364.47 Million CNY	-12.59%
2019 Q3	416.97 Million CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q4	416.97 Million CNY	0.0%
2019 FY	416.97 Million CNY	49.34%
2018 FY	279.21 Million CNY	0.0%

Peer Total Assets Comparison of Immunotech Biopharm Ltd

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-106.415%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	92.476%